Novo Nordisk

YTD

ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Novo Nordisk and other ETFs, options, and stocks.

About NVO

Novo Nordisk A/S is a global healthcare company, which engages in the discovery, development, manufacturing and marketing of pharmaceutical products. It operates through the Diabetes and Obesity Care and Rare Disease segments.

CEO

Maziar Mike Doustdar

CEOMaziar Mike Doustdar

Employees

68,794

Employees68,794

Headquarters

Bagsværd, Capital Region

HeadquartersBagsværd, Capital Region

Founded

1923

Founded1923

Employees

68,794

Employees68,794

NVO Key Statistics

Market cap

201.56B

Market cap201.56B

Price-Earnings ratio

11.38

Price-Earnings ratio11.38

Dividend yield

2.64%

Dividend yield2.64%

Average volume

10.12M

Average volume10.12M

High today

$45.97

High today$45.97

Low today

$45.24

Low today$45.24

Open price

$45.58

Open price$45.58

Volume

7.18M

Volume7.18M

52 Week high

$64.16

52 Week high$64.16

52 Week low

$35.12

52 Week low$35.12

NVO News

Barron's 2h

GLP1 Drugs Work for Kids, Says Novo Nordisk. They Could Be Another Huge Market. - Barron's

...

Nasdaq 3h

Is Novo Nordisk Stock Still Too Cheap for Investors to Ignore?

Key Points Novo Nordisk was first to market with a GLP-1 weight-loss drug, but lost the lead to Eli Lilly. Novo Nordisk has been working hard to regain lost m...

Seeking Alpha 10h

Novo Nordisk faces fresh setback as it halts two heart drug trials

Novo Nordisk (NVO) has halted two late-stage trials of its experimental heart drug ziltivekimab, adding to the drugmaker’s recent pipeline setbacks. The Danish...

More NVO News

TipRanks 22h

Novo Nordisk halts two trials testing ziltivekimab, Bloomberg reports

Novo Nordisk (NVO) has halted two trials testing if ziltivekimab, its experimental heart disease medicine, would help patients with heart failure, Ashleigh Furl...

TipRanks 1d

Novo Nordisk announces STEP Young phase 3 trial met its primary endpoint

Novo Nordisk (NVO) announced first results from the STEP Young phase 3 trial, evaluating once-weekly semaglutide in combination with a reduced-calorie diet and...

TipRanks 1d

Novo Nordisk Hit by Another Heart Drug Setback

Novo Nordisk (NVO) has halted two late‑stage studies of its experimental heart drug ziltivekimab, marking a major setback in its push into cardiovascular medici...

Nasdaq 1d

Novo Nordisk: STEP Young Phase 3 Trial With Semaglutide Shows Superior BMI Reduction At Week 68

(RTTNews) - Novo Nordisk (NVO, NOVOB.CO, NOV.DE) announced first results from the STEP Young phase 3 trial, evaluating once-weekly semaglutide in combination wi...

The Wall Street Journal 1d

Novo Nordisk Says Wegovy Shot Helped Children Lose Weight in Trial

Overall safety and tolerability of the drug were consistent with previous trials in children and adults. Shelby Knowles / Bloomberg Novo Nordisk NOVO.B -0.13 %...

TipRanks 2d

Clever Culture Systems Wins Expanded Novo Nordisk Order as APAS Nears Global Validation

The latest update is out from LBT Innovations Limited ( (AU:CC5) ). Clever Culture Systems Ltd, an Adelaide-based specialist in AI microbiology automation, has...

The Motley Fool 3d

Viking Therapeutics Trades Well Below Its Wall Street Targets. Here's the Skeptics' Case.

According to Yahoo! Finance, the consensus price target from analysts for Viking Therapeutics (VKTX +2.62%) is about $92, which indicates potential upside of 16...

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.